Source: Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach



Rating:

Share or cite this content

Citations should be made in the following way:
T. Peikert (Rochester, United States of America). Pulmonary-renal interaction. Pulmonary involvement in kidney diseases. Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement in inflammatory bowel disease Source: Annual Congress 2010 - Pulmonary involvement in disorders of the gastrointestinal system Year: 2010 Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease? Source: Annual Congress 2010 - New mechanisms in chronic lung diseases Year: 2010 Pulmonary involvement in children with rheumatic diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Therapeutic update of severe pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Developing pulmonary rehabilitation in interstitial lung disease Source: Annual Congress 2010 - PG22 Postgraduate Course: Developing pulmonary rehabilitation in non-COPD patients Year: 2010 Metabolic syndrome and lung disease: the link of inflammation and stem cell failure Source: Annual Congress 2011 - The modern pulmonologist consultant in a general hospital: the importance of an holistic approach Year: 2011 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary function involvement in scleroderma Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models Year: 2011 Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 LATE-BREAKING ABSTRACT: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Ethical issues in idiopathic pulmonary fibrosis with acute respiratory failure (IPF-ARF): An Italian survey Source: Annual Congress 2011 - Noninvasive ventilation on the intensive care unit: from novel application to end of life issues Year: 2011 Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Pulmonary involvement in rheumatological diseases in children Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Pulmonary hypertension in chronic interstitial lung diseases}, Source: Eur Respir Rev 2013; 22: 292-301 Year: 2013